ELSI Advisory Group (ELSIag)
The Ethical, Legal and Social Implications advisory group (ELSIag) addresses ethical, legal and social issues that SPHN will face.
The ELSI Advisory Group is composed of experts from various relevant fields such as bioethics, life sciences law, social sciences.
It also includes representatives of the Swiss Academy of Medical Sciences (SAMS), swissethics, and patient advocacy groups.
Members
Prof. Andrea Büchler
Private and comparative law
(UZH)
Dr. med. Susanne Driessen
Research ethics
(swissethics)
Prof. Matthias Baumgartner
Rare diseases, clinical science
(UZH / KISPI)
David Haerry
Patient advocacy
(EUPATI)
Prof. Samia Hurst
Bioethics
(UNIGE)
Prof. Beat Rudin
Data protection
(Privatim)
Prof. Effy Vayena
Bioethics, health policy
Chairperson of the ELSIag
(ETHZ)
(ETHZ)
Ex officio members
Dr. Thomas Geiger
Managing Director SPHN
 
 
(SAMS)
Former members
- Dr. Caroline Brall, Public health ethics, research ethics, ethics education (ex officio)
- Prof. Jacques Fellay, Genomics, Clinical Science (CHUV / EPFL)
- Cyrill Berger, Data protection law (Office of the Federal Data Protection and Information Commissioner)
- Dorothée Caminiti, Health law, bioethics, policy (ex officio)
- Prof. Annegret Hannawa, Patient safety, communication science (Università della Svizzera italiana)
- Ursula Koch, Patient advocacy (Krebsliga)
- Thomas H. Meier, Data protection law (Office of the Federal Data Protection and Information Commissioner)
- Prof. Francesco Panese, Studies of the relations between science, medicine and society (University of Lausanne)
- Prof. Brigitte Tag, Health law, human subject research act (University of Zurich)
- Prof. Jacques de Werra, Internet, information and IP laws (University of Geneva)